Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case–control comparisons and a meta-analysis of published VDR data
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
We have carried out melanoma case-control comparisons for six vitamin D receptor (VDR) gene single nucleotide polymorphisms (SNPs) and serum 25-hydroxyvitamin D(3) levels in order to investigate the role of vitamin D in melanoma susceptibility. There was no significant evidence of an association between any VDR SNP and risk in 1028 population-ascertained cases and 402 controls from Leeds, UK. In a second Leeds case-control study (299 cases and 560 controls) the FokI T allele was associated with increased melanoma risk (odds ratio (OR) 1.42, 95% confidence interval (CI) 1.06-1.91, p=0.02). In a meta-analysis in conjunction with published data from other smaller data sets (total 3769 cases and 3636 controls), the FokI T allele was associated with increased melanoma risk (OR 1.19, 95% CI 1.05-1.35), and the BsmI A allele was associated with a reduced risk (OR 0.81, 95% CI 0.72-0.92), in each instance under a parsimonious dominant model. In the first Leeds case-control comparison cases were more likely to have a higher body mass index (BMI) than controls (p=0.007 for linear trend). There was no evidence of a case-control difference in serum 25-hydroxyvitamin D(3) levels. In 1043 incident cases from the first Leeds case-control study, a single estimation of serum 25-hydroxyvitamin D(3) level taken at recruitment was inversely correlated with Breslow thickness (p=0.03 for linear trend). These data provide evidence to support the view that vitamin D and VDR may have a small but potentially important role in melanoma susceptibility, and putatively a greater role in disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Picconi, O., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.016 · Cited by 1,266 · cited 2×
“Sunburn and intense intermittent sun exposure are associated with an increased risk of melanoma (28, 29).”
BackgroundGenetic determinants of hair, eye and skin pigmentation in Europeans
Sulem, P., Gudbjartsson, D. F., Stacey, S. N., Helgason, A., Rafnar, T., Magnusson, K. P., Manolescu, A., Karason, A., Palsson, A., Thorleifsson, G., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.13 · Cited by 750 · cited 1×
“Recent large-scale association studies have shown that the genetic determinants of some of these phenotypes, such as red hair and freckles (3), are also risk factors for melanoma (4, 5).”
BackgroundNewton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y.-M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1135 · Cited by 295 · cited 2×
“Recently we have produced data supportive of an effect of serum vitamin D on survival from melanoma (NewtonBishop et al 2009, in press)(45).”
BackgroundResultSelf-citationPolymorphisms in the MTHFR and VDR genes and skin cancer risk
Han, J., Colditz, G. A., & Hunter, D. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl156 · Cited by 110
Cited by
Marsden, J. R., Newton-Bishop, J. A., Burrows, L., Cook, M., Corrie, P. G., Cox, N. H., Gore, M. E., Lorigan, P., MacKie, R., Nathan, P., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09883.x · Cited by 396
Self-citationSlominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Expression of vitamin D receptor decreases during progression of pigmented skin lesions
Brożyna, A. A., Jozwicki, W., Janjetovic, Z., & Slominski, A. T. (2011) · Human Pathology · doi:10.1016/j.humpath.2010.09.014 · Cited by 120
“These results are in agreement with cell culture–based studies that suggested a role for VDR in biology of melanomas [21,22] as well as with populationbased studies showing that VDR gene polymorphism [27,30,32,33] or local generation of vitamin D or levels of circulating 25(OH)D3 [6,25,28,29] can alter disease suscept…”
BackgroundResultVaidya, A., Sun, B., Forman, J. P., Hopkins, P. N., Brown, N. J., Kolatkar, N. S., Williams, G. H., & Williams, J. S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03991.x · Cited by 58
Pre-Diagnostic Circulating Vitamin D and Risk of Melanoma in Men
Major, J. M., Kiruthu, C., Weinstein, S. J., Horst, R. L., Snyder, K., Virtamo, J., & Albanes, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035112 · Cited by 35
“The primary etiologic factor for melanoma is solar ultraviolet (UV) radiation exposure [3–5], but interest in the potential role of circulating high vitamin D concentrations has increased owing in part to recently observed associations with reduced melanoma tumor progression and improved survival [6–8].”
Background
Metadata
- Authors
- Randerson-Moor, J. A., Taylor, J. C., Elliott, F., Chang, Y.-M., Beswick, S., Kukalizch, K., Affleck, P., Leake, S., Haynes, S., Karpavicius, B., Marsden, J., Gerry, E., Bale, L., Bertram, C., Field, H., Barth, J. H., Silva, I. D. S., Swerdlow, A., Kanetsky, P. A., Barrett, J. H., Bishop, D. T., & Bishop, J. A. N.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 45
- Issue
- 18
- Pages
- 3271-3281
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2090690075
- Cited by
- 147
- References
- 5
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.